Abstract
Ganoderma lucidum polysaccharides are the primary active constituents of Ganoderma lucidum. Existing researches indicate that they possess multiple pharmacological effects and benefits, including anti-tumor, antioxidant, anti-aging, hypoglycemic, and immune-modulating properties. Studies on the cellular impact of Ganoderma polysaccharides have predominantly focused on various cell types, including malignant tumor cells, immune cells, cardiac myocytes, neurons, hepatocytes, and fibroblasts. In this paper, we review and summarize recent literature primarily related to these pharmacological effects at the cellular level and their underlying mechanisms. Our aim is to provide insights and references for the deep clinical development and utilization of Ganoderma lucidum polysaccharides.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
